Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$41.11 USD
+0.28 (0.69%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $41.11 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth F Momentum C VGM
Earnings News For AMPH
-
Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
-
Amphastar: Q4 Earnings Snapshot
-
Amphastar (AMPH) to Report Q4 Earnings: What's in the Cards?
-
Amphastar: Q3 Earnings Snapshot
-
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
-
Amphastar: Q2 Earnings Snapshot
-
Amphastar (AMPH) to Report Q2 Earnings: What's in the Cards?
-
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
-
Amphastar: Q1 Earnings Snapshot
-
Amphastar: Q4 Earnings Snapshot
-
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Beat Estimates
-
Amphastar Pharmaceuticals (AMPH) Q3 Earnings Meet Estimates
-
Amphastar: Q3 Earnings Snapshot
-
Earnings Preview: Amphastar Pharmaceuticals (AMPH) Q3 Earnings Expected to Decline
-
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
-
Amphastar: Q2 Earnings Snapshot
-
Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Top Estimates
-
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: Should You Buy?
-
Amphastar Pharmaceuticals (AMPH) Tops Q4 Earnings and Revenue Estimates
-
Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Beat Estimates
-
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: What to Know Ahead of Q3 Release
-
Amphastar Pharmaceuticals (AMPH) Meets Q2 Earnings Estimates
-
Amphastar Pharmaceuticals (AMPH) to Report Q2 Results: Wall Street Expects Earnings Growth
-
Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Top Estimates
-
Amphastar Pharmaceuticals (AMPH) to Report Q1 Results: Wall Street Expects Earnings Growth